Toth K - Search Results

1

A phase I, pharmacokinetic and pharmacodynamic study on vorinostat in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with refractory colorectal cancer.

Fakih MG, Pendyala L, Fetterly G, Toth K, Zwiebel JA, Espinoza-Delgado I, Litwin A, Rustum YM, Ross ME, Holleran JL, Egorin MJ. Fakih MG, et al. Among authors: toth k. Clin Cancer Res. 2009 May 1;15(9):3189-95. doi: 10.1158/1078-0432.CCR-08-2999. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383814 Free PMC article. Clinical Trial.

2

Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model.

Cao S, Lu K, Tóth K, Slocum HK, Shirasaka T, Rustum YM. Cao S, et al. Among authors: toth k. Clin Cancer Res. 1999 Feb;5(2):267-74. Clin Cancer Res. 1999. PMID: 10037174

3

d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.

Vanhoefer U, Cao S, Minderman H, Toth K, Skenderis BS 2nd, Slovak ML, Rustum YM. Vanhoefer U, et al. Among authors: toth k. Clin Cancer Res. 1996 Dec;2(12):1961-8. Clin Cancer Res. 1996. PMID: 9816155

4

PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.

Vanhoefer U, Cao S, Minderman H, Tóth K, Scheper RJ, Slovak ML, Rustum YM. Vanhoefer U, et al. Among authors: toth k. Clin Cancer Res. 1996 Feb;2(2):369-77. Clin Cancer Res. 1996. PMID: 9816180

5

Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.

Guo B, Cao S, Tóth K, Azrak RG, Rustum YM. Guo B, et al. Among authors: toth k. Clin Cancer Res. 2000 Feb;6(2):718-24. Clin Cancer Res. 2000. PMID: 10690558

6

S-phase modulation by irinotecan: pilot studies in advanced solid tumors.

Ramnath N, Khushalani N, Toth K, Litwin AM, Intengan ME, Slocum HK, Pendyala L, Smith PF, Stewart CC, Hoffman JL, Javle MM, Berdzik J, Creaven PJ, Rustum YM. Ramnath N, et al. Among authors: toth k. Cancer Chemother Pharmacol. 2005 Nov;56(5):447-54. doi: 10.1007/s00280-004-0951-6. Epub 2005 Jun 10. Cancer Chemother Pharmacol. 2005. PMID: 15947933 Clinical Trial.

7

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models.

Cao S, Durrani FA, Tóth K, Rustum YM. Cao S, et al. Among authors: toth k. Br J Cancer. 2014 Apr 2;110(7):1733-43. doi: 10.1038/bjc.2014.85. Epub 2014 Mar 11. Br J Cancer. 2014. PMID: 24619073 Free PMC article.

8

A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance.

Minderman H, Vanhoefer U, Toth K, Minderman MD, Rustum YM. Minderman H, et al. Among authors: toth k. Cancer. 1996 Dec 1;78(11):2427-36. Cancer. 1996. PMID: 8941015

9

Translational studies of glutathione in bladder cancer cell lines and human specimens.

Pendyala L, Velagapudi S, Toth K, Zdanowicz J, Glaves D, Slocum H, Perez R, Huben R, Creaven PJ, Raghavan D. Pendyala L, et al. Among authors: toth k. Clin Cancer Res. 1997 May;3(5):793-8. Clin Cancer Res. 1997. PMID: 9815751

10

MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

Tóth K, Vaughan MM, Peress NS, Slocum HK, Rustum YM. Tóth K, et al. Am J Pathol. 1996 Sep;149(3):853-8. Am J Pathol. 1996. PMID: 8780389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,183 results

Search Page

Filters